Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuation of Follow-up of DES-Exposed Cohorts

NCT00340600 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00340600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00340600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuation of Follow-up of DES-Exposed Cohorts
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
March 18, 1998
Completion date
November 13, 2020
Enrollment
10,805 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune disease, breast cancer, endometrial cancer, ovarian cancer, prostate cancer